// App-Quantinova.ai

e13074 : Huge heterogeneity of patient characteristics, treatment patterns, hospital costs exists in non-small cell lung cancer surgeries among different centers of China: A study of 5060 patients based on the Chinese national NSCLC outcome registry.

Researchers

Presenter

  • Jian Zhou

Principal Investigators

  • Yanguo Liu

  • Yin Li

  • Lin Xu

  • Lingbin Du

  • Xianzhen Liao

  • Xiaotao Zhang

  • Aishan Jin

  • Chenlong Xu

  • Junfeng Liu

  • Hui Qiu

  • Lin Zhu

  • Yongzhen Zhang

  • Naiquan MAO

  • Changjun He

  • Yunchao Huang

  • Hao Li

  • Xun Wang

  • Jun Wang

Medical Centers

  • Peking University People's Hospital, Beijing, China

  • Henan Cancer Hospital, Zhengzhou, China

  • Jiangsu Cancer Hospital, Nanjing, China

  • Zhejiang Cancer Hospital, Hangzhou, China

  • Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China

  • Qingdao Center Hospital, Qingdao, China

  • Liaoning Cancer Hospital and Institute, Liaoning, China

  • Shandong Cancer Hospital, Jinan, China

  • Breast canter, Fourth Hospital of Hebei Medical University, Shijiazhuang, China

  • Chongqing Cancer Hospital, Chongqing, China

  • Xinjiang Uygur Autonomous Region Cancer Hospital, Urumqi, China

  • Shanxi Cancer Hospital, Shanxi, China

  • Guangxi cancer hospital, Nanning, China

  • Harbin Medical University Caner Hospital, Haerbing, China

  • Yunnan Tumor Hospital,The Third Affiliated Hospital of Kunming Medical University, Kunming, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final